Introduction to Lorbrena (Lorlatinib) 100mg
Lorbrena (Lorlatinib) 100mg is a targeted prescription medicine used in the treatment of advanced non-small cell lung cancer (NSCLC), especially in patients with ALK-positive mutations. This medicine belongs to a specialized class of oncology drugs that work by blocking specific proteins responsible for cancer growth.
Lorbrena (Lorlatinib) 100mg is classified under Prescription Medicines, Oncology Medicines, Anticancer Drugs, and Targeted Cancer Therapies. It contains Lorlatinib, a third-generation ALK inhibitor designed to overcome resistance from earlier treatments.
In some markets, Lorbrexen 100mg is available as a generic brand containing the same active ingredient Lorlatinib, offering similar therapeutic benefits when prescribed by a qualified healthcare professional.
What Is Lorbrena (Lorlatinib)?
Lorbrena is the brand name for Lorlatinib, an oral medication widely used in the treatment of ALK-positive metastatic non-small cell lung cancer.
Lorlatinib belongs to a class of medicines known as Tyrosine Kinase Inhibitors (TKIs). These medicines help block signals that cancer cells use to grow and spread.
Generic versions such as Lorbrexen 100mg contain the same active compound and may be used depending on physician recommendation and regional availability.
Drug Class and Mechanism of Action
Lorlatinib is classified as a targeted anti-cancer agent with strong antineoplastic activity.
How Lorlatinib Works
It works in several ways:
- Inhibits ALK (Anaplastic Lymphoma Kinase) and ROS1 proteins
- Blocks cancer cell signaling pathways
- Prevents tumor cell growth and spread
Through these mechanisms, Lorlatinib helps control disease progression in advanced lung cancer.
How Lorbrena Works in the Body
Cancer cells with ALK mutations grow rapidly due to abnormal signaling. Lorbrena works by targeting these mutations directly.
Key Actions of Lorlatinib
- Blocks ALK mutation-driven cancer growth
- Penetrates the brain to treat metastases
- Slows down or stops tumor progression
Generic versions such as Lorbrexen deliver the same active compound for targeted therapy.
Medical Uses of Lorbrena (Lorlatinib) 100mg
Lorbrena 100mg is mainly prescribed for advanced lung cancer.
Non-Small Cell Lung Cancer (NSCLC)
Lorlatinib is used in patients with ALK-positive metastatic NSCLC, especially after progression on other ALK inhibitors.
Potential Benefits
- Effective in resistant ALK mutations
- Controls brain metastases
- Improves progression-free survival
Who Can Take Lorbrexen 100mg?
Because Lorlatinib is a potent targeted therapy, it should be used under specialist supervision.
Eligibility Criteria
Patients may be prescribed Lorbrena if they:
- Have ALK-positive metastatic NSCLC
- Have previously received ALK inhibitor therapy
- Can undergo regular monitoring
Who Should Avoid Lorbrena (Lorlatinib) 100mg
This medicine should NOT be used by:
- Patients with hypersensitivity to Lorlatinib
- Individuals with severe uncontrolled medical conditions
- Patients without confirmed ALK mutation
Lorbrena (Lorlatinib) 100mg Dosage and Administration
Standard Dosage Guidelines
Typical dosage includes:
- Lorlatinib 100mg once daily
- Taken with or without food
- Swallowed whole with water
Dosage Adjustments
Doctors may adjust dose based on:
- Side effects
- Liver function
- Drug interactions
Side Effects of Lorbrena 100mg
Common Side Effects
- High cholesterol levels
- Swelling (edema)
- Fatigue
- Weight gain
Serious Side Effects
- Central nervous system effects (mood changes, confusion)
- Lung inflammation
- Heart rhythm problems
Patients should immediately report unusual symptoms.
Storage:
Store below 30°C in a dry place, away from direct sunlight and moisture. Keep out of reach of children.
Frequently Asked Questions (FAQs)
1. Is Lorbrena (Lorlatinib) 100mg used after other treatments fail?
Yes, it is commonly used after resistance develops to earlier ALK inhibitors.
2. Can Lorlatinib treat brain metastases?
Yes, it is effective in treating brain metastases due to its ability to cross the blood-brain barrier.
3. Is it chemotherapy?
No, it is a targeted therapy, not traditional chemotherapy.
4. How long should treatment continue?
Treatment continues as long as it remains effective and tolerable.
5. Can pregnant women take Lorbrexen 100mg?
No. It may harm the unborn baby and should be avoided during pregnancy.
6. Is Lorbrexen 100mg the same as Lorbrena?
Yes, it contains Lorlatinib, the same active ingredient.
7. Do I need a prescription?
Yes, it is strictly a prescription-only medicine.
Medical Disclaimer
Disclaimer:
This content is for informational purposes only and should not be considered medical advice. Lorbrena (Lorlatinib) is a prescription-only medicine and must be used under the supervision of a qualified healthcare professional.
